Akèy › Ateroskleroz › Arizona › Tucson

Etid klinik pou Ateroskleroz nan Tucson, AZ

5 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Tucson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2

Pima Heart, Tucson
Eclipse Clinical Research, Tucson

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3

Pima Heart, Tucson
Eclipse Clinical Research, Tucson

Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3

AKDHC Medical, Tucson
Southern Arizona VA Health Care System, Tucson

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3

Research Site, Tucson
Research Site, Tucson

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Ap rekriteFaz 4

Southern Arizona VA Health Care System, Tucson, AZ, Tucson

Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198

Etid Ateroskleroz nan lòt vil

Lòt etid nan Tucson

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.